Last reviewed · How we verify

NCT06085066

The Role of Modified Ultrafiltration Following Open Heart Surgery

Completed NA Last updated 15 March 2024
What this trial tests

NA trial testing Conventional Ultrafiltration alone on Cardiopulmonary bypass in Heart; Surgery, Heart, Functional Disturbance as Result in 38 participants. Completed in 29 February 2024.

Timeline
1 December 2021
Primary endpoint
31 December 2023
29 February 2024

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment38
Start date1 December 2021
Primary completion31 December 2023
Estimated completion29 February 2024
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

18 and older, any sex, with Heart; Surgery, Heart, Functional Disturbance as Result. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effect of combining conventional ultrafiltration and modified ultrafiltration compared to conventional ultrafiltration alone in patients who underwent open heart surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Heart; Surgery, Heart, Functional Disturbance as Result

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06085066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing